AUTHORS
John Bliamptis, MD, Hannah King, MD2, Michael Choi, MD3, Srila Gopal, MD4
AFFILIATIONS
1 University of California San Diego, La Jolla, California, United States
2 University of California San Diego, La Jolla, California, United States
3 University of California San Diego, La Jolla, California, United States
4 University of California San Diego, La Jolla, California, United States
ABSTRACT
In 2021, we implemented a telemedicine-guided infusion center (IC) triage model to facilitate outpatient management of acute uncomplicated vaso-occlusive episodes (AVOE) in patients with sickle cell disease (SCD). The model decreased emergency department (ED) utilization at the population level while improving delivery of evidence-based care using existing institutional resources. We identified a subset of patients with frequent IC visits, suggesting use of the IC for management of chronic SCD-related pain. To address this challenge, we implemented interventions aimed at (1) enhancing triage processes to appropriately direct chronic pain management and reduce reliance on parenteral opioids, and (2) increasing IC access for patients presenting with AVOE throughout our health system.
We developed an electronic health record (EHR)-based registry to identify patients with SCD who had been seen in an ED setting for AVOE without yet establishing with our comprehensive SCD center. We informed these patients of our SCD program and helped them establish care. To reduce reliance on parenteral opioids for chronic pain, we reviewed patient history and prior IC utilization, incorporated pain chronicity into triage decisions, and limited IC visits to one per week for patients with high IC utilization or established chronic pain. To accommodate more patients seeking IC based management, we created an EHR-based multidisciplinary communication channel including staff across infusion center locations to expand access to available infusion appointments generated through same-day cancellations.
We performed a retrospective cross-sectional comparison of patients with SCD during the early IC phase (2021-2022) and the improved IC phase (2024-2025). Inpatient (IP) admissions, ED visits, and IC contacts were extracted from the EHR.
Our registry identified 223 patients who had acute care visits during the improved IC phase and 134 patients during the early IC phase over the study period. The overall number of IC visits increased from 1151 in the early IC phase to 1656 in the improved IC phase. The number of patients who utilized the IC went from 53 to 108 patients, which reflects an increase from 39.6% to 48.4% of the population with any acute care visit type during each period. Exclusive IC users, defined as patients who did not use the ED or require inpatient (IP) admission during the study period, rose from 9 (17.0% of IC users) in the early IC phase to 50 (46.3%) during the improved phase IC (Fisher's exact, p=0.00003).
We successfully improved our triage process and identified patients with high burden of prior IC visits and chronic pain. Median IC contacts per user declined from 7 to 2.5 (Mann-Whitney U, p=0.0037). Median ED visits per patient decreased from 1 to 0 (p=0.0008), while median IP admissions per patient remained unchanged at 1 (p=0.513). The correlation between IC contact frequency and ED utilization strengthened significantly (Spearman r: 0.32 increased to 0.62, Fisher's r-to-z p=0.02); the correlation with IP admissions showed a similar but non-significant trend (Spearman r: 0.50 changed to 0.68, p=0.102).
We observed measurable success following targeted improvements in our telemedicine-based AVOE IC management model. Registry-driven outreach coincided with broader IC reach. With improved communication channels and collaborative process improvements, we were able to increase the total number of IC visits, and the number of IC users more than doubled. There was a significant increase in the number of patients who used the IC exclusively for AVOE management.
Successful integration of our chronic pain team, IC visit limits for high utilizers, and attention to chronicity of pain while triaging during the improved IC phase coincided with a decline in median IC contacts per user, consistent with IC visits becoming more tightly tied to AVOE care rather than chronic pain. This did not lead to a compensatory increase in other acute care utilization, as median ED visits per patient decreased in the improved IC phase and IP admissions did not significantly change. There continued to be a strong association between IC visits and ED visits. Despite our process improvements, a small subpopulation of patients found it challenging to manage chronic pain without acute care services. Future work will focus on this subpopulation to optimize care of their chronic pain mindfully in accordance with American Society of Hematology guidelines.
DISCLOSURES
John Bliamptis, MD: No relevant conflicts of interest to declare.